A three year study (2008)(2009)(2010)(2011) on the validation of the Trichoderma technology for growth promoting ability of Trichoderma harzianum (Th3) was evaluated in the popular wheat (Triticum aestivum L.) variety Raj 3765 at farmer's field through TIFAC-DST project entitled "On Farm Demonstration and Commercial Production of Trichoderma as Biopesticide and Growth Promoter". The biological formulation was developed at Biological Control Laboratory, Division of Plant Pathology, IARI, New Delhi, and was successfully demonstrated in two districts of Rajasthan viz., Jaipur and Kota belonging to different agro climatic zones. Rhizospheric Competence Index along with its growth promotion effect on rootlets, tillers, weight of grains and grain yield were evaluated by using it at three stages of crop viz., seed, flowering and preharvesting @ 4g/kg and @ 4ml/L along with soil treatment with a mixture of farm yard manure and formulation @ 50:1 before sowing. Compared to the first year where the farmers were unaware of Trichoderma in 2008-09, a significant increase in yield of wheat from 36.25 to 46.73Q/ha (29% in Jaipur) and from 36.88 to 50.12Q/ha (36% in Kota) has been observed after continuous application for three years (2008)(2009)(2010)(2011) The total income and the benefit cost ratio of farmers increased both at Jaipur (Rs 56242/ha, 1:1.8) and Kota (Rs 60332/ha, 1:1.9).
Multi-location supervised field trials were conducted in India at four locations of the All India Network Project (AINP) on Pesticide Residues to study the persistence, dissipation and risk assessment of flubendiamide and deltamethrin on cucumber (Cucumis sativus). Residues of flubendiamide and deltamethrin on cucumber resulting from three spray applications of a combination formulation (flubendiamide 90% + deltamethrin 60%, 150 SC) at recommended (22.5 + 15 g a.i./ha) and double the recommended (45 + 30 g a.i./ha) dose were analysed. On the basis of persistence and dissipation studies, the half- life (T) of flubendiamide on cucumber varied from 1.40 to 2.98 (recommended dose) and 1.55 to 2.76 days (double the recommended dose), while that of deltamethrin ranged from 2.5 to 4.9 (recommended dose) and 2.7 to 3.9 days (double the recommended dose) at the four locations. On the basis of supervised field trial data and using OECD calculator, MRLs in the combination product of 3 mg kg for flubendiamide and 1.5 mg kg for deltamethrin has been proposed for consideration by the Food Safety and Standards Authority of India (FSSAI). Codex, EU and EPA have fixed MRL of 0.2 mg kg for flubendiamide and deltamethrin.
Minimization of power loss is the first priority of the power companies. Generally power loss is directly proportional to the reactive power demand and minimization of this is known as reactive power optimization (RPO). In this paper we are trying to minimize the reactive power loss with help of distributed generation. Distributed generation provides active as well as reactive power locally so, there is no need of taking the reactive power from the generator consequently reactive power loss minimizes. Now problem arises that where to place the distributed generation to have minimum power loss. To find the optimal location of the distributed generation, we have used particle swarm optimization algorithm (PSO). For that we have defined the fitness function as well as constraints. Constraints limits the value of variable within the defined range. Fitness function is sum of real power loss index, reactive power loss index and voltage deviation index. We have also used genetic algorithm just to compare the results and to find which one is better out of genetic algorithm and PSO. RPO increases the power transfer capability, reduces the line loss and boost the system stability therefore it can be applied in the distribution network.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.